Literature DB >> 11333002

The impact of substance abuse treatment modality on birth weight and health care expenditures.

M Daley1, M Argeriou, D McCarty, J J Callahan, D S Shepard, C N Williams.   

Abstract

During the 1990s, substance abuse treatment programs were developed for pregnant women to help improve infant birth outcomes, reduce maternal drug dependency and promote positive lifestyle changes. This study compared the relative impact of five treatment modalities--residential, outpatient, residential/outpatient, methadone and detoxification-only--on infant birth weight and perinatal health care expenditures for a sample of 445 Medicaid-eligible pregnant women who received treatment in Massachusetts between 1992 and 1997. Costs and outcomes were measured using the Addiction Severity Index and data from birth certificates, substance abuse treatment records and Medicaid claims. Multiple regression was used to control for intake differences between the groups. Results showed a near linear relationship between birth weight and amount of treatment received. Women who received the most treatment (the residential/outpatient group) delivered infants who were 190 grams heavier than those who received the least treatment (the detoxification-only group) for an additional cost of $17,211. Outpatient programs were the most cost-effective option, increasing birth weight by 139 grams over detoxification-only for an investment of only $1,788 in additional health care and treatment costs. A second regression using five intermediate treatment outcomes--prenatal care, weight gain, relapse, tobacco use and infection--suggested that increases in birth weight were due primarily to improved nutrition and reduced drug use, behaviors which are perhaps more easily influenced in residential settings.

Entities:  

Mesh:

Year:  2001        PMID: 11333002     DOI: 10.1080/02791072.2001.10400469

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  7 in total

1.  Reciprocal obligations: managing policy responses to prenatal substance exposure.

Authors:  Peter D Jacobson; Gail L Zellman; C Christine Fair
Journal:  Milbank Q       Date:  2003       Impact factor: 4.911

Review 2.  Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.

Authors:  Jennifer Prah Ruger; Christina M Lazar
Journal:  Addict Behav       Date:  2011-08-05       Impact factor: 3.913

3.  Should pregnant women with substance use disorders be managed differently?

Authors:  Verena Metz; Birgit Köchl; Gabriele Fischer
Journal:  Neuropsychiatry (London)       Date:  2012-01-25

4.  Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord.

Authors:  Ana de Castro; Marta Concheiro; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-07-24       Impact factor: 3.205

5.  Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry.

Authors:  Ana de Castro; Marta Concheiro; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-06       Impact factor: 3.367

6.  Costs of a motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice for pregnant substance users.

Authors:  Xiao Xu; Kimberly A Yonkers; Jennifer P Ruger
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

7.  Economic evaluation of a behavioral intervention versus brief advice for substance use treatment in pregnant women: results from a randomized controlled trial.

Authors:  Xiao Xu; Kimberly A Yonkers; Jennifer Prah Ruger
Journal:  BMC Pregnancy Childbirth       Date:  2017-03-07       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.